Literature DB >> 23440878

Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.

Jinyuan Zhou1, He Zhu, Michael Lim, Lindsay Blair, Alfredo Quinones-Hinojosa, Steven A Messina, Charles G Eberhart, Martin G Pomper, John Laterra, Peter B Barker, Peter C M van Zijl, Jaishri O Blakeley.   

Abstract

PURPOSE: To investigate the feasibility of a three-dimensional amide-proton-transfer (APT) imaging sequence with gradient- and spin-echo readouts at 3 Tesla in patients with high- or low-grade gliomas.
MATERIALS AND METHODS: Fourteen patients with newly diagnosed gliomas were recruited. After B0 inhomogeneity correction on a voxel-by-voxel basis, APT-weighted images were reconstructed using a magnetization-transfer-ratio asymmetry at offsets of ±3.5 ppm with respect to the water resonance. Analysis of variance post hoc tests were used for statistical evaluations, and results were validated with pathology.
RESULTS: In six patients with gadolinium-enhancing high-grade gliomas, enhancing tumors on the postcontrast T1 -weighted images were consistently hyperintense on the APT-weighted images. Increased APT-weighted signal intensity was also clearly visible in two pathologically proven, high-grade gliomas without gadolinium enhancement. The average APT-weighted signal was significantly higher in the lesions than in the contralateral normal-appearing brain tissue (P < 0.001). In six low-grade gliomas, including two with gadolinium enhancement, APT-weighted imaging showed iso-intensity or mild punctate hyperintensity within all the lesions, which was significantly lower than that seen in the high-grade gliomas (P < 0.001).
CONCLUSION: The proposed three-dimensional APT imaging sequence can be incorporated into standard brain MRI protocols for patients with malignant gliomas.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CEST imaging; Key Words: APT imaging; gadolinium enhancement; glioma; tumor grade

Mesh:

Substances:

Year:  2013        PMID: 23440878      PMCID: PMC3664658          DOI: 10.1002/jmri.24067

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  37 in total

Review 1.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.

Authors:  A Dean Sherry; Mark Woods
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

2.  Amide proton transfer imaging of human brain tumors at 3T.

Authors:  Craig K Jones; Michael J Schlosser; Peter C M van Zijl; Martin G Pomper; Xavier Golay; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

Review 3.  Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults.

Authors:  Riyadh N Al-Okaili; Jaroslaw Krejza; Sumei Wang; John H Woo; Elias R Melhem
Journal:  Radiographics       Date:  2006-10       Impact factor: 5.333

4.  In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T.

Authors:  Craig K Jones; Daniel Polders; Jun Hua; He Zhu; Hans J Hoogduin; Jinyuan Zhou; Peter Luijten; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2011-11-14       Impact factor: 4.668

5.  Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T.

Authors:  Xuna Zhao; Zhibo Wen; Fanheng Huang; Shilong Lu; Xianlong Wang; Shuguang Hu; Donglin Zu; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2011-03-10       Impact factor: 4.668

6.  Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments.

Authors:  Mina Kim; Joseph Gillen; Bennett A Landman; Jinyuan Zhou; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2009-06       Impact factor: 4.668

7.  Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma.

Authors:  Susan M Chang; Sarah Nelson; Scott Vandenberg; Soonmee Cha; Michael Prados; Nicholas Butowski; Michael McDermott; Andrew T Parsa; Manish Aghi; Jennifer Clarke; Mitchel Berger
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

8.  Simultaneous B(0)- and B(1)+-map acquisition for fast localized shim, frequency, and RF power determination in the heart at 3 T.

Authors:  Michael Schär; Evert-Jan Vonken; Matthias Stuber
Journal:  Magn Reson Med       Date:  2010-02       Impact factor: 4.668

9.  Magnetic resonance image-guided proteomics of human glioblastoma multiforme.

Authors:  Susan K Hobbs; Gongyi Shi; Ron Homer; Griff Harsh; Scott W Atlas; Mark D Bednarski
Journal:  J Magn Reson Imaging       Date:  2003-11       Impact factor: 4.813

10.  Magnetic resonance imaging of glutamate.

Authors:  Kejia Cai; Mohammad Haris; Anup Singh; Feliks Kogan; Joel H Greenberg; Hari Hariharan; John A Detre; Ravinder Reddy
Journal:  Nat Med       Date:  2012-01-22       Impact factor: 53.440

View more
  97 in total

1.  Chemical exchange saturation transfer MRI using intermolecular double-quantum coherences with multiple refocusing pulses.

Authors:  Jianhua Lu; Congbo Cai; Shuhui Cai; Zhong Chen; Jinyuan Zhou
Journal:  Magn Reson Imaging       Date:  2014-03-14       Impact factor: 2.546

2.  Improving the detection sensitivity of pH-weighted amide proton transfer MRI in acute stroke patients using extrapolated semisolid magnetization transfer reference signals.

Authors:  Hye-Young Heo; Yi Zhang; Tina M Burton; Shanshan Jiang; Yansong Zhao; Peter C M van Zijl; Richard Leigh; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-06-21       Impact factor: 4.668

3.  Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI.

Authors:  Meiyun Wang; Xiaohua Hong; Che-Feng Chang; Qiang Li; Bo Ma; Hong Zhang; Sinan Xiang; Hye-Young Heo; Yi Zhang; Dong-Hoon Lee; Shanshan Jiang; Richard Leigh; Raymond C Koehler; Peter C M van Zijl; Jian Wang; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-04-16       Impact factor: 4.668

4.  Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.

Authors:  Jiaxuan Zhang; Wenzhen Zhu; Rongwen Tain; Xiaohong Joe Zhou; Kejia Cai
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

5.  Ultrafast compartmentalized relaxation time mapping with linear algebraic modeling.

Authors:  Yi Zhang; Xiaoyang Liu; Jinyuan Zhou; Paul A Bottomley
Journal:  Magn Reson Med       Date:  2017-04-11       Impact factor: 4.668

6.  Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.

Authors:  Ayan Debnath; Rakesh Kumar Gupta; Anup Singh
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

7.  Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.

Authors:  Shanshan Jiang; Tianyu Zou; Charles G Eberhart; Maria A V Villalobos; Hye-Young Heo; Yi Zhang; Yu Wang; Xianlong Wang; Hao Yu; Yongxing Du; Peter C M van Zijl; Zhibo Wen; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-07-16       Impact factor: 4.668

8.  Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.

Authors:  C Su; C Liu; L Zhao; J Jiang; J Zhang; S Li; W Zhu; J Wang
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

9.  Observation of true and pseudo NOE signals using CEST-MRI and CEST-MRS sequences with and without lipid suppression.

Authors:  Jianhua Lu; Jinyuan Zhou; Congbo Cai; Shuhui Cai; Zhong Chen
Journal:  Magn Reson Med       Date:  2014-05-06       Impact factor: 4.668

Review 10.  Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum.

Authors:  Peter C M van Zijl; Wilfred W Lam; Jiadi Xu; Linda Knutsson; Greg J Stanisz
Journal:  Neuroimage       Date:  2017-04-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.